Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer
Likun Li, Styliani Karanika, Guang Yang, Jiangxiang Wang, Sanghee Park, Bradley M. Broom, Ganiraju C. Manyam, Wenhui Wu, Yong Luo, Spyridon Basourakos, Jian H. Song, Gary E. Gallick, Theodoros Karantanos, Dimitrios Korentzelos, Abul Kalam Azad, Jeri Kim, Paul G. Corn, Ana M. Aparicio, Christopher J. Logothetis, Particia TroncosoTimothy Heffernan, Carlo Toniatti, Hyun Sung Lee, Ju Seog Lee, Xuemei Zuo, Wenjun Chang, Jianhua Yin, Timothy C. Thompson
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer'. Together they form a unique fingerprint.